54.46 USD
+1.98 (+3.77%)
54.5 USD
+0.04 (+0.07%)
BRKR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. BRKR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BRKR was profitable.
BRKR had a positive operating cash flow in the past year.
In the past 5 years BRKR has always been profitable.
Each year in the past 5 years BRKR had a positive operating cash flow.
1.2 Ratios
BRKR has a Return On Assets of -0.37%. This is in the better half of the industry: BRKR outperforms 64.91% of its industry peers.
The Return On Equity of BRKR (-0.97%) is better than 64.91% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.01%, BRKR is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BRKR is below the industry average of 14.00%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKR's Profit Margin has declined in the last couple of years.
The Operating Margin of BRKR (8.99%) is better than 66.67% of its industry peers.
In the last couple of years the Operating Margin of BRKR has declined.
With a Gross Margin value of 48.00%, BRKR perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
Compared to 5 years ago, BRKR has less shares outstanding
Compared to 1 year ago, BRKR has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.65 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score of 2.65. This is comparable to the rest of the industry: BRKR outperforms 57.89% of its industry peers.
BRKR has a Debt/Equity ratio of 0.82. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
BRKR has a Debt to Equity ratio of 0.82. This is in the lower half of the industry: BRKR underperforms 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.65 |
ROIC/WACC0.39
WACC10.21%
2.3 Liquidity
A Current Ratio of 1.85 indicates that BRKR should not have too much problems paying its short term obligations.
BRKR's Current ratio of 1.85 is on the low side compared to the rest of the industry. BRKR is outperformed by 63.16% of its industry peers.
A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
The Quick ratio of BRKR (0.89) is worse than 85.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.10% in the past year.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
The Earnings Per Share is expected to grow by 5.58% on average over the next years.
The Revenue is expected to grow by 3.38% on average over the next years.
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 27.23, which means the current valuation is very expensive for BRKR.
Based on the Price/Earnings ratio, BRKR is valued cheaply inside the industry as 80.70% of the companies are valued more expensively.
BRKR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.19.
Based on the Price/Forward Earnings ratio of 24.98, the valuation of BRKR can be described as rather expensive.
82.46% of the companies in the same industry are more expensive than BRKR, based on the Price/Forward Earnings ratio.
BRKR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.23 | ||
| Fwd PE | 24.98 |
4.2 Price Multiples
BRKR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRKR is cheaper than 80.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 19.06 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)3.04
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
5. Dividend
5.1 Amount
With a yearly dividend of 0.38%, BRKR is not a good candidate for dividend investing.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.09. BRKR pays more dividend than 89.47% of the companies in the same industry.
With a Dividend Yield of 0.38, BRKR pays less dividend than the S&P500 average, which is at 1.90.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has paid a dividend for at least 10 years, which is a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
BRKR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
BRKR's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
54.46
+1.98 (+3.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners90.2%
Inst Owner Change0%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap8.27B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts79.09
Price Target51.65 (-5.16%)
Short Float %11.12%
Short Ratio4.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)8.84%
PT rev (3m)12.88%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-24.3%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-4.48%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.23 | ||
| Fwd PE | 24.98 | ||
| P/S | 2.41 | ||
| P/FCF | N/A | ||
| P/OCF | 87.75 | ||
| P/B | 3.4 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.06 |
EPS(TTM)2
EY3.67%
EPS(NY)2.18
Fwd EY4%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.14%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)3.04
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.65 |
F-Score5
WACC10.21%
ROIC/WACC0.39
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year9.99%
EBIT Next 3Y11.38%
EBIT Next 5Y10.68%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status for BRKR stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for BRKR stock?
The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 27.23 and the Price/Book (PB) ratio is 3.4.
What is the financial health of BRUKER CORP (BRKR) stock?
The financial health rating of BRUKER CORP (BRKR) is 2 / 10.